Infinium Medical, through its Infinium Veterinary division will be exclusively distributing Vapotherm VET 2.0 high-velocity respiratory therapy systems. This partnership allows us to provide ...
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® ...
EXETER, N.H., Oct. 24, 2025 /PRNewswire/ -- Vapotherm, Inc., a global leader in mask-free noninvasive respiratory support, announced its HVT® 2.0 system has received Authority to Operate (ATO) ...
According to a Future Market Insights (FMI) analysis, the High Flow Oxygen Therapy Devices Market size was held at around US$ 1.7 billion in 2021. Overall sales of High Flow Oxygen Therapy Devices are ...
Joe Army, Vapotherm's President and Chief Executive Officer expressed his optimism, stating, "I'm excited about emerging market growth for Vapotherm. In the third quarter of 2023, we posted 25% global ...
"High Flow Oxygen Therapy Devices Market"The global high-flow oxygen therapy devices market is estimated to grow at a CAGR of 2.31% during the forecast period from 2025 to 2032. The global High-Flow ...
The study, led by Dr. Charles Atwood, evaluated 26 hypercapnic COPD patients in a randomized crossover trial. The results showed that patients using the Unicorn Cannula experienced comparable relief ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback